Elagolix sodium
Elagolix sodium is a potent and selective GnRH receptor antagonist, with reported IC50 and Ki values of 0.25 nM and 3.7 nM, respectively. It is utilized in research to investigate gonadotropin suppression in preclinical models of endometriosis and uterine fibroids, both in vitro and in vivo.
Product Specifications
CAS Number
832720-36-2
Product Name Alternative
Inhibitor, Elagolix, Elagolix sodium, GnRH Receptor, GNRHR, GNRH Receptor, GnRHR, GNRHReceptor, Gonadotropin releasing hormone receptor, NBI56418, NBI-56418, NBI-56418 sodium, NBI 56418, inhibit
Field of Research
Pharmacology & Drug Discovery
Purity
99.71% (May vary between batches)
Solubility
DMSO:27.78 mg/mL (42.51 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (3.06 mM) ; H2O:50 mg/mL (76.5 mM)
Smiles
[Na+].COc1cccc (c1F) -c1c (C) n (Cc2c (F) cccc2C (F) (F) F) c (=O) n (C[C@H] (NCCCC ([O-]) =O) c2ccccc2) c1=O
Molecular Formula
C32H29F5N3NaO5
Molecular Weight
653.57
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
NIF3L1-6064M 50 µg
Recombinant Mouse NIF3L1 Protein, His (Fc)-Avi-tagged
Sign In for Pricing
View Details 
MBS6285632-01 0.1 mL
CHIC2, CT (CHIC2, BTL, Cysteine-rich hydrophobic domain 2 protein, BrX-like translocated in leukemia) (MaxLight 750)
Sign In for Pricing
View Details MBS6285632-02 5x 0.1 mL
CHIC2, CT (CHIC2, BTL, Cysteine-rich hydrophobic domain 2 protein, BrX-like translocated in leukemia) (MaxLight 750)
Sign In for Pricing
View Details 
MBS1388192-01 0.02 mg (E-Coli)
Recombinant Oryza sativa subsp. japonica Monothiol glutaredoxin-S4, mitochondrial (GRXS4)
Sign In for Pricing
View Details 
MBS1388192-02 0.1 mg (E-Coli)
Recombinant Oryza sativa subsp. japonica Monothiol glutaredoxin-S4, mitochondrial (GRXS4)
Sign In for Pricing
View Details